NutriBand Inc. (NTRB) - Dilution Analysis

10-K filing | 11.6M shares outstanding

10-Q filing | 11.2M shares outstanding

8-K filing: Nutriband Inc. authorized 2,788,678 shares of Series A Convertible Preferred Stock and approved a preferred stock dividend of one share of Series A Preferred stock for each four shares of common stock owned.

POS AM filing: This is a post-effective amendment to a registration statement for the issuance of common stock upon the exercise of outstanding warrants, along with recent financings and corporate developments.

POS AM filing: This POS AM filing relates to the potential issuance of 957,980 shares of common stock upon exercise of warrants from a 2021 public offering and to a previous combination offering, also registering the underlying common stock and warrants.

10-Q filing | 11.1M shares outstanding

10-K filing | 10.6M shares outstanding

10-Q filing | 11.1M shares outstanding

10-Q filing | 11.1M shares outstanding

POS AM filing: This POS AM filing relates to the registration of 959,005 common shares issuable upon exercise of warrants from a 2021 offering and provides an update on the April 19, 2024 equity financing.

POS AM filing: This POS AM filing relates to the issuance of 959,005 shares of Nutriband Inc. common stock upon the exercise of outstanding warrants from a prior IPO.

10-Q filing | 11.0M shares outstanding

8-K filing: Issuance of 76,230 shares of common stock upon conversion of $300,000 principal and accrued interest on a convertible note held by TII Jet Services LDA at a price of $4.00 per share. ($0.3M proceeds)

10-K filing | 11.0M shares outstanding

8-K filing: The company reports unregistered sales of equity securities in the form of options and warrants to purchase common stock, and an amendment to the Employee Stock Option Plan increasing the number of shares available.

8-K filing: TII Jet Services LDA converted $2,000,000 of outstanding principal and accrued interest into 1,026,720 shares of Common Stock at $2.00 per share. ($2.0M proceeds)

10-Q filing | 7.8M shares outstanding

10-Q filing | 7.8M shares outstanding

RW filing: The company withdrew the registration statement due to recent trading prices and a $3,000,000 increase in the company's credit line facility.

S-1/A filing: Nutriband Inc. is offering 1,101,928 shares of common stock, with the underwriters having an option to purchase up to an additional 165,289 shares.

S-1/A filing: This S-1/A filing relates to a proposed offering of common stock, with the net proceeds intended for research and development of an abuse-deterrent fentanyl transdermal system and for working capital and other corporate purposes. The underwriters have an option to purchase additional shares.

10-Q filing | 7.8M shares outstanding

S-1 filing: S-1 filing for an offering of common stock, with underwriters having an option to purchase additional shares. The company intends to use the net proceeds primarily for research and development and for working capital and other corporate purposes.

10-K filing | 7.9M shares outstanding

10-Q filing | 7.8M shares outstanding

10-Q filing | 7.4M shares outstanding

8-K filing: Stock split 7-for-6 | Outstanding: 7,843,671 → 9,150,949

POS AM filing: This is a POS AM filing for Nutriband Inc. related to a previously consummated unit offering, each unit consisting of one share of common stock and a warrant to purchase one share of common stock.

POS AM filing: This is a POS AM filing detailing previous offerings, including convertible notes, warrants, and a unit offering consisting of common stock and warrants. It also discusses the implications of being an emerging growth company.

10-Q filing | 7.9M shares outstanding

POS AM filing: This is a POS AM filing that discusses previous convertible note offerings, warrant issuances, and a public offering of units consisting of common stock and warrants.

10-K filing | 7.8M shares outstanding

10-Q filing | 7.8M shares outstanding

POS AM filing: This prospectus relates to the resale by the selling stockholders of up to 141,828 shares of Nutriband Inc.'s common stock, of which 46,828 shares were issued in recent private placements, and 95,000 shares relate to the resale of shares that are issuable upon the exercise of certain outstanding warrants.

8-K filing: The company consummated a public offering of 1,056,00 units, each unit consisting of one share of common stock and one warrant at a price of $6.25 per unit, and an additional 158,400 warrants pursuant to exercise of the underwriters' over-allotment option, receiving net proceeds of $5,836,230. ($5.84M proceeds)

S-1/A filing: This is an S-1/A filing for an offering of 1,056,000 Units, each consisting of one share of common stock and one Warrant, each whole Warrant exercisable for one share of common stock. The underwriters have an option for a period of 45 days to purchase up to an additional 158,400 shares of our common stock and/or Warrants to purchase up to 158,400 additional shares of our common stock.

S-1/A filing: S-1/A filing for offering of 750,000 Units, each consisting of one share of common stock and one Warrant. The underwriters have an option for a period of 45 days to purchase up to an additional 112,500 shares of our common stock and/or Warrants.

S-1 filing: The company is offering 750,000 Units, each consisting of one share of common stock and one Warrant, each whole Warrant exercisable for one share of common stock. The Warrants included with the Units are exercisable immediately, have an exercise price of $9.60 per share and expire five (5) years from the date of issuance.

10-Q filing | 6.4M shares outstanding

10-Q filing | 6.4M shares outstanding

10-K filing | 6.4M shares outstanding

8-K filing: BPM Inno Ltd. purchased 81,396 shares of common stock at $8.60 per share for a total of $700,000 on February 26, 2021, as part of a Stock Purchase Agreement. ($0.7M proceeds)

8-K filing: The company sold unregistered common stock to directors, management, and consultants on January 5, 2021, at a price of $15.00 per share. ($78.23M proceeds)

10-Q filing | 6.1M shares outstanding

10-Q filing | 5.5M shares outstanding

10-Q filing | 5.5M shares outstanding

S-1/A filing: This S-1/A filing relates to the resale by selling stockholders of up to 141,828 shares of common stock. 46,828 shares were issued in recent private placements, and 95,000 shares are issuable upon the exercise of certain outstanding warrants.

S-1/A filing: This S-1/A filing relates to the resale by selling stockholders of up to 141,828 shares of common stock, including shares from private placements and shares issuable upon exercise of warrants.

S-1 filing: This S-1 filing relates to the resale of up to 166,828 shares of common stock by selling stockholders, including shares issued in private placements and shares issuable upon the exercise of outstanding warrants.

10-K filing | 5.4M shares outstanding

8-K filing: On March 22, 2020, the Company issued 46,828 units at $11 per unit, each consisting of one share of common stock and a warrant. On March 31, 2020, the Company issued 25,000 shares of common stock upon conversion of notes. ($0.52M proceeds)

RW filing: The Company has determined at this time not to proceed with the offering due to unfavorable market conditions and requests that the Commission consent to this application on the grounds that withdrawal of the Registration Statement is consistent with the public interest and the protection of investors